BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15952745)

  • 1. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic protein discovery using proteolytic peptide targeting and identification.
    Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
    Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting.
    Koomen JM; Zhao H; Li D; Nasser W; Hawke DH; Abbruzzese JL; Baggerly KA; Kobayashi R
    Rapid Commun Mass Spectrom; 2005; 19(12):1624-36. PubMed ID: 15915451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.
    Koomen JM; Shih LN; Coombes KR; Li D; Xiao LC; Fidler IJ; Abbruzzese JL; Kobayashi R
    Clin Cancer Res; 2005 Feb; 11(3):1110-8. PubMed ID: 15709178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of protein fragments as pattern features in MALDI-MS analyses of serum.
    Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC
    J Proteome Res; 2005; 4(5):1672-80. PubMed ID: 16212420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted comparative proteomics by liquid chromatography/matrix-assisted laser desorption/ionization triple-quadrupole mass spectrometry.
    Melanson JE; Chisholm KA; Pinto DM
    Rapid Commun Mass Spectrom; 2006; 20(5):904-10. PubMed ID: 16470697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
    Pernemalm M; Orre LM; Lengqvist J; Wikström P; Lewensohn R; Lehtiö J
    J Proteome Res; 2008 Jul; 7(7):2712-22. PubMed ID: 18549256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal preparation methods for automated matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling of low molecular weight proteins and peptides.
    Penno MA; Ernst M; Hoffmann P
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2656-62. PubMed ID: 19630030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.
    Vallant RM; Szabo Z; Trojer L; Najam-ul-Haq M; Rainer M; Huck CW; Bakry R; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):44-53. PubMed ID: 17203947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.